Hui Liu

Hui Liu is a seasoned microbiologist with extensive experience in medical technologies and research. Currently serving as a Principal Microbiologist at Kyocera Medical Technologies, Inc. since 2019, responsibilities include overseeing cleaning, sterilization, and biocompatibility for medical implants and surgical instruments, as well as managing validation studies and compliance documentation. Previous roles include Senior Microbiologist at Renovis Surgical Technologies, where work focused on evaluating microRNA-based drugs, and Principal Scientist at Zimmer, leading R&D efforts for tissue preservation products. Early career highlights include postdoctoral research at The University of Texas at Austin on embryonic stem cell dynamics and significant contributions as a Research Scientist at Peking University, where a novel anti-stroke medication was developed. Hui Liu earned a Ph.D. in Microbiology and Immunology from The University of Texas at Austin.